The Game Developers Conference will be held in San Francisco from March 18-22, 2019. To commemorate the GDC, we will highlight two gaming patents during the conference. U.S. Patent No. 10,157,521 B2 (‘521), issued on December 18, 2018, for “Identification of Side Pot Participants in Poker Game.” The inventors are Jacob Moore of Alameda, California, …
Category: patent
CannabIP: U.S. Patent No. 10,085,965 B2
U.S. Patent No. 10,085,965 B2 (‘965) issued on October 2, 2018, for “Cannabinoid Alcoholic Drink.” It was issued to applicants/inventors Olga Skuratovich of Denver, Colorado and Filipp Mirzakhanov of Centennial, Colorado. The sole ‘965 claim is directed to a method of producing a drink consisting of cannabidiol (CBD) and vodka. It is interesting that the …
Fed Circuit Watch: Pre-Critical Date Surgeries Not Invalidating Public Uses
In the first split precedential decision of 2019 by the Court of Appeals for the Federal Circuit, the Fed Circuit assessed the issues of invalidating public disclosure versus an inventor’s exception to experimentally perfect an invention for its intended purpose. That case, Barry v. Medtronic, Inc.,[1] decided on January 24, 2019, split heavily because of …
CannabIP: U.S. Patent No. 10,011,804 B2
U.S. Patent No. 10,011,804 B2 (‘804) issued on July 3, 2018, for “Method of Extracting CBD, THC, and Other Compounds From Cannabis Using Controlled Cavitation.” It was issued to inventor Douglas G. Mancosky of White, Georgia. The applicant is Hydro Dynamics, Inc., a cross-industry cavitation extraction company located in Rome, Georgia. The assignee is EcoXtraction, …
Fed Circuit Watch: USPTO Botched Patent Term Adjustment Calculation
On January 23, 2018, the Court of Appeals for the Federal Circuit decided Supernus Pharmaceuticals, Inc. v. Iancu,[1] in which the Fed Circuit found defective the USPTO’s calculation of patent term adjustment (PTA) under 35 U.S.C. §154(b), a rather unexciting and mostly mechanical aspect of patent prosecution. Supernus Pharmaceuticals owns U.S. Patent No. 8,747,897 (‘897) …
Fed Circuit Watch: Another Mayo, Another §101 Kill
Medical diagnostics patents involving a certain lab testing company named Mayo took a hit when those patents were deemed invalid under 35 U.S.C. §101. No, it’s not that Mayo case,[1] but the one in which the Court of Appeals for the Federal Circuit recently decided on February 6, 2019, Athena Diagnostics, Inc. v. Mayo Collaborative …
TechPat: U.S. Patent No. D835,596 S: MWC Edition
Mobile World Congress opens in Barcelona, Spain, on February 25-28, 2019. To commemorate the mobile industry’s largest trade show, this blog will showcase various recently issued U.S. patents related to mobile technology. U.S. Patent No. D835,596 S (‘596) issued on December 11, 2018, for “Mobile Phone.” It was issued to inventors Minsu Cho and Beyoung …
TechPat: U.S. Patent No. D834,588 S: MWC Edition
Mobile World Congress opens in Barcelona, Spain, on February 25-28, 2019. To commemorate the mobile industry’s largest trade show, this blog will showcase various recently issued U.S. patents related to mobile technology. U.S. Patent No. D834,588 S (‘588) issued on November 27, 2018, for “Display Screen with Graphical User Interface for a Prompt Animation.” It …
CannabIP: U.S. Patent No. 10,039,740 B2
U.S. Patent No. 10,039,740 B2 (‘740) issued on August 7, 2018, for “Therapeutic Combinations of Sesquiterpenes and Flavonoids.” It was issued to inventor Masayoshi Yamaguchi of Shizuoka, Japan. The applicant/assignee is Primus Pharmaceuticals, Inc. of Scottsdale, Arizona, a pharmaceutical company which focuses on nutrition-based drug research. The ‘740 claims are directed to a composition of …
PlantIP: U.S. Patent No. PP29,981 P2
U.S. Patent No. PP29,981 P2 (‘981) issued on December 11, 2018, for “Heuchera Plant Named “Orange Dream’.” It was issued to inventor/applicant Thierry Delabroye of Hantay, France. The assignee is Sandrine Delabroye, of Hantay, France. This patent is a plant patent under 35 U.S.C. §161, which protects new and distinct cultivars of plants. According to …